NCT05318924View on ClinicalTrials.gov

Effects of Ghrelin Administration on Dopamine and Effort

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 21, 2022

Primary Completion Date

December 20, 2023

Study Completion Date

October 31, 2024

Conditions
Major Depressive Disorder
Interventions
DRUG

Ghrelin

Participants will receive an infusion that is intended to raise ghrelin level up to a steady plateau.

OTHER

Placebo

Participants will receive a saline infusion as the placebo control condition.

Trial Locations (1)

72076

RECRUITING

Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

lead

University Hospital Tuebingen

OTHER